Multicenter Phase I Trial of the Mitogen-Activated Protein Kinase 1/2 Inhibitor BAY 86-9766 in Patients with Advanced Cancer
WEEKES, Colin D, VON HOFF, Daniel D, MA, Wen W, SHEEDY, Beth, IVERSON, Cory, MINER, Jeffrey N, ZANCONG SHEN, YEH, Li-Tain, DUBOWY, Ronald L, JEFFERS, Michael, RAJAGOPALAN, Prabhu, CLENDENINN, Neil J, ADJEI, Alex A, LEFFINGWELL, Diane P, ECKHARDT, S. Gail, GORE, Lia, LEWIS, Karl D, WEISS, Glen J, RAMANATHAN, Ramesh K, DY, Grace K
Published in Clinical cancer research (01.03.2013)
Published in Clinical cancer research (01.03.2013)
Get full text
Journal Article
A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer
Adjei, Alex A, Richards, Donald A, El-Khoueiry, Anthony, Braiteh, Fadi, Becerra, Carlos H R, Stephenson, Jr, Joe J, Hezel, Aram F, Sherman, Morris, Garbo, Lawrence, Leffingwell, Diane P, Iverson, Cory, Miner, Jeffrey N, Shen, Zancong, Yeh, Li-Tain, Gunawan, Sonny, Wilson, David M, Manhard, Kimberly J, Rajagopalan, Prabhu, Krissel, Heiko, Clendeninn, Neil J
Published in Clinical cancer research (15.05.2016)
Published in Clinical cancer research (15.05.2016)
Get full text
Journal Article
The Pharmacology and Clinical Use of Methotrexate
Jolivet, Jacques, Cowan, Kenneth H, Curt, Gregory A, Clendeninn, Neil J, Chabner, Bruce A
Published in The New England journal of medicine (03.11.1983)
Published in The New England journal of medicine (03.11.1983)
Get full text
Journal Article
Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder
KHORSAND, M, LANGE, J, FEUN, L, CLENDENINN, N. J, COLLIER, M, WILDING, G
Published in Investigational new drugs (01.01.1997)
Published in Investigational new drugs (01.01.1997)
Get full text
Journal Article
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule
ADAMSON, P. C, BALIS, F. M, MISER, J, ARNDT, C, WELLS, R. J, GILLESPIE, A, ARONSON, L, PENTA, J. S, CLENDENINN, N. J, POPLACK, D. G
Published in Cancer research (Chicago, Ill.) (01.02.1992)
Get full text
Published in Cancer research (Chicago, Ill.) (01.02.1992)
Journal Article
Predictors of optimal virological response to potent antiretroviral therapy
POWDERLY, W. G, SAAG, M. S, CHAPMAN, S, YU, G, QUART, B, CLENDENINN, N. J
Published in AIDS (London) (01.10.1999)
Published in AIDS (London) (01.10.1999)
Get full text
Journal Article
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule
Adamson, P C, Balis, F M, Miser, J, Wells, R J, Bleyer, W A, Williams, T E, Gillespie, A, Penta, J S, Clendeninn, N J, Poplack, D G
Published in Cancer research (Chicago, Ill.) (01.08.1990)
Get full text
Published in Cancer research (Chicago, Ill.) (01.08.1990)
Journal Article
Abstract A88: Safety, pharmacokinetic, and pharmacodynamic results of BAY 86–9766, an oral MEK inhibitor, in combination with sorafenib, an oral multikinase inhibitor, in advanced cancer patients
Adjei, Alex A., Richards, Donald A., El-Khoueiry, Anthony, Becerra, Carlos H.R., Stephenson, Joe J., Leffingwell, Diane P., Iverson, Cory, Miner, Jeffrey N., Shen, Zancong, Gunawan, Sonny, Wilson, David, Manhard, Kimberly J., Dubowy, Ron L., Jeffers, Michael, Rajagopalan, Prabhu, Franklin, Wilbur A., Haney, Jerry, Lenhart, Patricia, Clendeninn, Neil J.
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
A pilot study of piritrexim in mycosis fungoides
Zackheim, H S, Springer, E A, Brown, P J, Wintroub, B U, Clendeninn, N J
Published in Archives of dermatology (1960) (01.04.1992)
Published in Archives of dermatology (1960) (01.04.1992)
Get more information
Journal Article
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks
ROBERTS, J. D, SHIBATA, S, PARADISO, L. J, CLENDENINN, N. J, SPICER, D. V, MCLEOD, H. L, TOMBES, M. B, KYLE, B, CARROLL, M, SHEEDY, B, COLLIER, M. A, PITHAVALA, Y. K
Published in Cancer chemotherapy and pharmacology (2000)
Published in Cancer chemotherapy and pharmacology (2000)
Get full text
Journal Article
Initial clinical trial and pharmacokinetics of Thymitaq TM (AG337) by 10-day continuous infusion in patients with advanced solid tumors
Creaven, Patrick J., Pendyala, Lakshmi, Meropol, Neal J., Clendeninn, Neil J., Wu, Ellen Y., Loewen, Gregory M., Proefrock, April, Johnston, Amanda, Dixon, Mary
Published in Cancer chemotherapy and pharmacology (25.11.1997)
Published in Cancer chemotherapy and pharmacology (25.11.1997)
Get full text
Journal Article
Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusion
O'DWYER, P. J, LAUB, P. B, GALLO, J. M, DEMARIA, D, QIAN, M, REILLY, D, GIANTONIO, B, JOHNSTON, A. L, WU, E. Y, BAUMAN, L, CLENDENINN, N. J
Published in Clinical cancer research (01.10.1996)
Get full text
Published in Clinical cancer research (01.10.1996)
Journal Article
Phase I trial of piritrexim capsules using prolonged, low-dose oral administration for the treatment of advanced malignancies
Feun, L G, Savaraj, N, Benedetto, P, Hanlon, J, Sridhar, K S, Collier, M, Richman, S, Liao, S H, Clendeninn, N J
Published in JNCI : Journal of the National Cancer Institute (02.01.1991)
Published in JNCI : Journal of the National Cancer Institute (02.01.1991)
Get more information
Journal Article
A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer
Vokes, Everett E., Dimery, Isaiah W., Jacobs, Charlotte D., Karp, Daniel, Molina, Arturo, Collier, Mary A., Eble, Melody L., Clendeninn, Neil J.
Published in Cancer (01.05.1991)
Published in Cancer (01.05.1991)
Get full text
Journal Article
A phase II study of piritrexim in patients with advanced squamous head and neck cancer
Uen, Wu‐Ching, Huang, Andrew T., Mennel, Robert, Jones, Stephen E., Spaulding, Monica B., Killion, Kathleen, Havlin, Kathleen, Keegan, Patricia, Clendeninn, Neil J.
Published in Cancer (15.02.1992)
Published in Cancer (15.02.1992)
Get full text
Journal Article
Oral piritrexim--a phase II study in patients with advanced soft tissue sarcoma
Schiesel, J D, Carabasi, M, Magill, G, Casper, E, Cheng, E, Marks, L, Feyzi, J, Clendeninn, N J, Smalley, R V
Published in Investigational new drugs (01.07.1992)
Published in Investigational new drugs (01.07.1992)
Get more information
Journal Article
Phase I evaluation of 773U82-HCl in a two-hour infusion repeated daily for three days
Bailey, H, Kohler, P, Tuttle, R, Carbone, P P, Hohneker, J A, Clendeninn, N J, Wilding, G
Published in Investigational new drugs (01.11.1992)
Published in Investigational new drugs (01.11.1992)
Get more information
Journal Article
Phase I clinical and pharmacology study of 502U83 given as a 24-h continuous intravenous infusion
Schilsky, R L, Ratain, M J, Janisch, L, Vogelzang, N J, Lucas, V S, Ravitch, J, Hohneker, J A, Clendeninn, N J, Tuttle, R L
Published in Cancer chemotherapy and pharmacology (01.01.1993)
Published in Cancer chemotherapy and pharmacology (01.01.1993)
Get more information
Journal Article